|Day Low/High||33.18 / 36.15|
|52 Wk Low/High||9.00 / 35.08|
The only companies that have Phase 2 clinical trials now are Compass Pathways, Mind Medicine, Cybin, and Mydecine Innovations.
Georgia's election results have given the industry a big green light, meaning positive moves are expected out of cannabis stocks.
Let's take a fresh look at the charts and indicators.
Aphria investors will have a larger stake in the combined company post-merger.
This is the first time that any cannabis bill addressing descheduling has been approved by Congress.
There were several reasons why the 2020 supply fell from 2019 levels.
A 'green wave' has advanced cannabis legalization across America. And that's just one of the forces powering up pot stocks right now.
Collective Growth Corp is the first and largest SPAC focused on building the U.S. commercial hemp supply chain.
Can corporate America grow sales for the fourth quarter? Then answer a question with a question.
Let's review the charts of this cannabis firm to see if a sustained advance is ready to begin.
The potential of legal New York adult-use cannabis sales have been estimated at $1.5 billion a year by 2023.
Cannabis investors are keenly aware of the landscape and how it could play out for the industry.
Let's take a close look at Canopy Growth, GrowGeneration and cannabis REIT Innovative Industrial Properties.
Just as we saw with pot stocks, if you play shares strictly because they're going up, you're likely to get burnt.
Ayr Strategies is expanding in a contracting market.
The amended deal between the two cannabis companies is a doozy.
I continue to recommend a reduced long exposure on STZ.
Publicly traded cannabis companies are expected to take big write downs on assets, and here's why it matters.
Real Money tapped an industry expert to discuss the outlook for buying and selling of cannabis companies.
If the Democrats sweep, you have perhaps the best single stock in the market.
Interpreting the flow of capital in theory, or at least historically, for equities is quite simple. It's about growth, or the lack thereof.
CGC has started to make its move to the upside, so let's see what the charts say and how to play this cannabis name.
The daily picture has my attention. The big watch here is the 50-day simple moving average.
There are 153,000 convenience stores in the U.S. and these outlets sell the bulk of the country's cigarettes.
Here's our latest trading strategy on STZ.
Here's how investors can trade the cannabis stock.